Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)

ArticlesBy José Correa Fernández27 October, 2022

Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1) Diego Benavent, Marco Garrido-Cumbrera, Chamaida Plasencia-Rodríguez,  Helena Marzo-Ortega, Laura Christen, José Correa-Fernández, Pedro Plazuelo-Ramos, Dale Webb and Victoria Navarro-Compán Ther Adv Musculoskelet Dis. 2022 Objective To evaluate the overall health and functioning in patients with axial…

Details

Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study

ArticlesBy José Correa Fernández27 October, 2022

Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study Marco Garrido-Cumbrera, David Gálvez-Ruiz, Carlos J Delgado-Domínguez, Denis Poddubnyy, Victoria Navarro-Compán, Laura Christen, Raj Mahapatra, Souzi Makri, Christine Bundy on behalf of the EMAS working group RMD open. 2021 Objective To determine the presence of mental disorder risk and associated factors…

Details

A Benchmarking Study Evaluating Axial Spondyloarthritis Burden in Spain and Other European Countries. Results from the Spanish Atlas and the European Map of Axial Spondyloarthritis (EMAS) Studies

ArticlesBy José Correa Fernández27 October, 2022

A Benchmarking Study Evaluating Axial Spondyloarthritis Burden in Spain and Other European Countries. Results from the Spanish Atlas and the European Map of Axial Spondyloarthritis (EMAS) Studies Marco Garrido-Cumbrera, Jordi Gratacós, Eduardo Collantes-Estevez, Pedro Zarco-Montejo, Carlos Sastre, Laura Christen, Sergio Sanz-Gómez, José Correa-Fernández, Victoria Navarro-Compán Int J Rheum Dis. 2021 Objective To compare the burden…

Details

Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis

ArticlesBy José Correa Fernández27 October, 2022

Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis Marco Garrido-Cumbrera, Victoria Navarro-Compán, Christine Bundy, Raj Mahapatra, Souzi Makri, José Correa-Fernández, Laura Christen, Carlos Jesús Delgado-Domínguez, Denis Poddubnyy, the EMAS Working Group Rheumatology. 2021 Objective To identify the parameters associated with self-reported diagnostic delay (DD) in axial…

Details

The HTR-US research group is participating in the EULAR annual European rheumatology congress (EULAR 2020 e-congress – June 2020)

NewsBy José Correa Fernández26 October, 2022

Since June 3 EULAR (European Annual Congress of Rheumatology) is taking place, which due to the COVID-19 pandemic, is being held virtually. The aim of the European Congress of Rheumatology EULAR is to provide a forum, at the highest level, for scientific (both clinical and basic research), educational and social exchange between professionals involved in…

Details

The Health & Territory Research (HTR) research group of the University of Seville is developing the REUMAVID survey (evaluation of the effects of the covid-19 pandemic on rheumatic patients in Spain – April 2020)

NewsBy José Correa Fernández25 October, 2022

The Health & Territory Research (HTR) research group at the University of Seville is developing the REUMAVID survey (Evaluation of the Effects of the COVID-19 Pandemic on Rheumatic Patients in Spain), promoted by the Spanish Coordinator of Spondyloarthritis Associations (CEADE), in collaboration with the Galician Rheumatology League, the Catalan Rheumatology League, the Spanish Patients’ Forum…

Details

Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1)

ArticlesBy José Correa Fernández25 October, 2022

Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) Stephanie Rose Harrison, Marco Garrido-Cumbrera, Victoria Navarro-Compán, José Correa-Fernández, Dale Webb, Laura Christen, Helena Marzo-Ortega Rheumatology Advances in Practice. 2021 Objective The aim was to compare the impact of the first wave of…

Details

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

ArticlesBy José Correa Fernández24 October, 2022

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Frazão Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-Gómez, José Correa-Fernández,…

Details

Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas

ArticlesBy José Correa Fernández24 October, 2022

Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas Pablo Irimia, Marco Garrido-Cumbrera, Sonia Santos-Lasaosa, Marta Aguirre-Vazquez, José  Correa-Fernández, Isabel Colomina and Patricia Pozo-Rosich Scientific Reports. 2021 Objective Identifying highly disabled patients or at high risk of psychiatric comorbidity is crucial for migraine management. The burden…

Details

Estimating the savings associated with a migraine-free life: results from the Spanish Atlas

ArticlesBy José Correa Fernández24 October, 2022

Estimating the savings associated with a migraine-free life: results from the Spanish Atlas Pablo Irimia, Marco Garrido-Cumbrera, Sonia Santos-Lasaosa, Olta Braçe, Isabel Colomina, Carles Blanch, Patricia Pozo-Rosich Eur J Neurol. 2020 Objective Migraine is a common and costly neurological disorder. The aims of this study were to quantify the costs of chronic (CM) and episodic…

Details